Ida Deleskog Lindstrom, Global Medical Affairs Director at Gene Solutions, shared a post on LinkedIn:
“Excited to be heading to Taipei for the 30th Annual Taiwan Joint Cancer Conference (TJCC) 2026!
Gene Solutions is proud to host our official Satellite Symposium: ‘Multi-Omics Liquid Biopsy in Action: Advancing Precision Oncology in Taiwan.’
- Saturday, 2 May 2026
- 15:00 – 17:00 (GMT+8)
- Meeting Room 701H, TaiNEX 2
I am honored to deliver the Welcome speech and join the panel discussion. We are privileged to have an outstanding international and local faculty, featuring Professor Herbert Loong, MBBS FRCP FASCO (CUHK) as our distinguished moderator, along with:
• Dr. Aaron Tan Chia-Ken – National Cancer Centre Singapore
• Dr. Tom Wei-Wu Chen – National Taiwan University Hospital
• Dr. Nai-Jung Chiang – Taipei Veterans General Hospital
• Dr. Le Son Tran – Principal Investigator and R&D Lead, Gene Solutions
• Dr. Duy Sinh Nguyen – Medical Oncologist and Medical Director, Gene Solutions
A big thank you to our incredible Taiwan team for all their hard work making this possible — looking forward to seeing you all there! Priscilla Low, Cheryl Hung and the whole team.
Together we will explore the real-world value of multi-omics liquid biopsy across all stages of cancer care — from scalable multi-cancer early detection with SPOT-MAS, to clinical applications in GI/colorectal, breast, sarcoma, and lung cancers, as well as the latest AI-driven biomarker integration in Asia-Pacific practice.
If you are attending TJCC, I warmly invite you to join us. Looking forward to meaningful discussions with oncology colleagues from Taiwan and across APAC as we push the boundaries of precision cancer medicine.”
Other articles featuring Ida Deleskog Lindstrom on OncoDaily.